Let's talk medical research

We recently announced a collaboration with Ben’s Friends, a network of online communities for people impacted by rare disease, and MyRareData, an organization that facilitates fundraising for advocacy groups through data, to bring information about clinical trials to the rare disease community.

With what we’re learning from the COVID-19 pandemic, can we create a permanent solution to keep the patient at the heart of clinical research? Last week a panel of experts, including our CEO, Laurent Schockmel, teamed up for an Ogilvy Consulting webinar, during which they discussed key industry considerations when it comes to putting patient centricity into action.

An interview with Lindsey Wahlstrom-Edwards, Head of Partnerships at Antidote

In 2018, Antidote worked with SCORR Marketing and eight leading health organizations, including the Melanoma Research Alliance (MRA), to survey 4,000 patients about clinical research. About 10% of the total respondents self-identified as having melanoma.

A Q&A with Yvonne Taylor, Antidote’s senior clinical site operations manager Digital vendors work closely with clinical trial sites to ensure patient enrollment is going smoothly. We spoke with our very own Senior Clinical Site Operations Manager, Yvonne Taylor, about how clinical trial sites and vendors can best work together to provide a straightforward enrollment process for patients.

Idiopathic pulmonary fibrosis (IPF) is a progressive disease that causes scarring of the lungs. Over time, the scarring worsens and it can become difficult to breathe. IPF has no cure and limited treatment options, making clinical research especially critical. In this case study, a pharma company approached Antidote to identify 600 IPF patients who would be eligible for their study in just six ...

In the midst of the COVID-19 pandemic, it seems like everything has gone digital, from scheduling video chat appointments with your doctor to Zoom conference calls, reading your newspapers online, and ordering groceries via an app. With the ability to reach more people online than ever before, clinical trial recruitment companies, too, have begun turning to digital channels even more to reach the ...

Does a health crisis change digital engagement behaviors? How should digital marketers respond?

Patient recruitment in clinical trials has a reputation for taking a long time and slowing down research. However, with the right patient recruitment strategies, enrolling patients doesn’t have to halt your trial’s progress. Below, you’ll find four strategies used by clinical trial patient recruitment companies to reach the “unreachable patient.”

Can we apply customer service models to healthcare? And what would that mean for clinical trial patient recruitment?